PURR
NASDAQ · Biotechnology

Hyperliquid Strategies

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.49
-0.25 (-2.86%)
As of Jun 29, 1:51 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +99.6% upside
Low Target $12.34
Average Target $16.95
High Target $26.10
Current Price $8.49
Current
$8.49
Target
$16.95
$12.34 $16.95 avg $26.10
Scenario Analysis
Bear Case
$12.34
45.3%
Low target
Base Case
$16.95
+99.6%
Avg target
Bull Case
$26.10
+207.4%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$11.62
-26.9% from high
52-Week Low
$3.01
+182.1% from low
Target vs 52W High
$16.95
+45.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +1.3%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.1%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -12.3%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.5%